S49076
S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM.
Product Specifications
CAS Number
1265965-22-7
UNSPSC
12352005
Hazard Statement
H302
Target
C-Met/HGFR; FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/S49076.html
Concentration
10mM
Purity
99.44
Solubility
DMSO : ≥ 31 mg/mL
Smiles
O=C(N1CC2=CC3=C(NC(/C3=C\C4=CC(CN5CCOCC5)=CN4)=O)C=C2)SCC1=O
Molecular Formula
C22H22N4O4S
Molecular Weight
438.50
Precautions
H302
References & Citations
[1]Burbridge MF, et al. S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. Mol Cancer Ther. 2013 Sep;12 (9) :1749-62.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0142002 1.0 µg DNA
ATG4A sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
CSB-BP338540DUB-01 20 µg
Recombinant Clostridium acetobutylicum Acetoacetate decarboxylase (adc)
Sign In for Pricing
View Details CSB-BP338540DUB-02 100 µg
Recombinant Clostridium acetobutylicum Acetoacetate decarboxylase (adc)
Sign In for Pricing
View Details CSB-BP338540DUB-03 1 mg
Recombinant Clostridium acetobutylicum Acetoacetate decarboxylase (adc)
Sign In for Pricing
View Details